Jin Jiang International is reportedly considering making an offer for HNA Group’s Radisson Hotel Group, KKR and TPG are the front-runners for Abraaj’s health care fund, and Carl Icahn plans to vote against Cigna’s proposed deal for Express Scripts.
National grocery company Albertsons LLC has urged a Texas federal court to dismiss a suit claiming it submitted false claims to Medicare and Medicaid for various drugs, arguing the same allegations had already been brought up in previous cases, one by the current plaintiff.
Allergan Finance LLC has hit Pfizer Inc. and a subsidiary with third-party claims in multidistrict litigation over the opioid crisis, arguing that Allergan should be indemnified for having to defend pre-2009 misleading marketing allegations relating to a prescription opioid.
A Florida appeals court on Wednesday tossed twin medical malpractice suits against University of Miami doctors treating patients at a public hospital as part of an affiliation agreement, saying the state Legislature’s 2011 decision to expand sovereign immunity to such doctors was not unconstitutional.
The U.S. attorney for Eastern Pennsylvania announced on Wednesday he is establishing an Affirmative Civil Enforcement Strike Force to investigate and prosecute the abuse of government programs — including health care and procurement fraud — plus enforce civil rights statutes and combat the opioid crisis.
California’s insurance commissioner urged the U.S. Department of Justice on Wednesday to block CVS Health Corp.'s planned $69 billion purchase of insurance provider Aetna Inc., saying the deal would drive up consumer costs and can’t be fixed.
State Farm on Wednesday accused three Florida health care clinics and the individuals running them of defrauding the insurance company of more than $4.7 million by billing for unnecessary or unprovided treatments for patients in automobile accidents.
A special master appointed to oversee a discovery dispute in multidistrict litigation over the opioid crisis partially granted a request by counties for more information from a McKesson Corp. investigation into suspicious drug order oversight, finding Wednesday the counties are entitled to witness names but that statements and terms used in the investigation are protected work product.
A federal grand jury has added over 100 counts, including health care fraud and money laundering charges, to the indictment against a former Pittsburgh-area physician already accused of illegally prescribing and distributing opioid painkillers.
The Third Circuit on Tuesday said U.S. Bank can't offset the $6.1 million it must pay the founder of National Medical Imaging for a tossed bankruptcy petition against money the executive owes, since the bank's filing was found to be in bad faith.
A National Labor Relations Board panel has ordered American Medical Response West to give its employees’ union the names of workers the company interviewed before firing a field training officer over sexual harassment allegations, saying Tuesday the union’s need for the names outweighs the business’ privacy concerns.
Two Illinois-based health care companies got slapped with separate proposed class actions in Illinois federal court by a home health care provider alleging the two sent it unwanted faxes advertising their services in violation of the Telephone Consumer Protection Act.
The Fifth Circuit has ruled that Aetna Life Insurance Co. can't sue an out-of-network Texas hospital for misrepresenting its billing practices, saying Aetna could not claim it was unaware of what those billing practices were.
The Federal Trade Commission said Wednesday that Spanish health care giant Grifols SA will sell blood plasma collection centers in three U.S. cities in order to win the regulator's approval of the company's proposed $286 million purchase of Florida-based Biotest US Corp.
The Trump administration on Wednesday gave health insurers the green light to sell lengthier policies that don’t include Affordable Care Act benefits and protections, asserting that slimmer coverage will help consumers who’ve been priced out of ACA marketplaces.
The Ninth Circuit on Tuesday revived a proposed class action claiming Costco misleadingly told shoppers that its stores offer eye exams by “independent” optometrists, saying the consumer plaintiff had adequately alleged that he was financially injured by the cost of the store-controlled eye doctor.
A California judge who ruled in May that coffee must carry cancer warnings said Tuesday that before entering an injunction requiring such labels, he would entertain arguments by Starbucks and other coffee companies that a rule being considered by a state environmental health agency would make the warnings unnecessary.
A Florida federal judge refused Monday to grant a new Medicare fraud trial to an ophthalmologist who escaped corruption charges last year alongside his longtime friend U.S. Sen. Bob Menendez, D-N.J., rejecting the doctor's claims that new evidence called for a do-over.
The Massachusetts Appeals Court on Tuesday affirmed a $32.5 million medical malpractice award that Atrius Health Inc. must pay the family of a patient who was paralyzed after her primary care doctor forgot to note a dangerous condition in her medical file.
A cardiologist was slammed with a 20-month prison sentence Tuesday in New Jersey federal court for defrauding the U.S. Department of Veterans Affairs out of nearly $240,000 by billing the agency for medical procedures he never performed.
Eighty years ago, President Franklin D. Roosevelt signed the Federal Food, Drug, and Cosmetic Act. In recognition of this anniversary, attorneys at Epstein Becker Green review how the act came to be, how it has evolved, and how the U.S. Food and Drug Administration is enforcing its authority under the act to address the demands of rapidly evolving technology.
The U.S. Food and Drug Administration recently provided drug and device manufacturers additional flexibility to convey certain types of truthful, nonmisleading product information. These guidance documents address FDA regulation of manufacturer communications, but the FDA still has work to do to complete its comprehensive review of policies in this area, say attorneys at Ropes & Gray LLP.
Legal industry compensation practices are once again in the news as BigLaw firms continue to match the new high watermark of $190,000 for first-year associate salaries. The typical model of increasing associate salaries uniformly fails star associates, the firms they work for and, ultimately, the clients they serve, says William Brewer, managing partner of Brewer Attorneys & Counselors.
This year, the U.S. Attorney's Office for the District of Massachusetts has investigated several life sciences companies for their donations to independent copay assistance charities. As the list of investigations grows longer, life sciences companies should reassess their policies, procedures and monitoring regarding donations, say attorneys at Paul Hastings LLP.
A recent report by the U.S. Government Accountability Office highlights the important role corporate integrity agreements play in protecting federal health care programs when federal laws are violated. Given their central role in promoting compliance, it is time for the U.S. Department of Health and Human Services’ Office of Inspector General to update its templates and approach, say attorneys with Skadden Arps Slate Meagher & Flom LLP.
While some may say it’s ironic, it’s also embarrassing and enraging that the very industry that offers anti-harassment training, policies and counsel now finds itself the subject of #MeToo headlines. The American Bar Association recommendation that will bring about the greatest change is the call to provide alternative methods for reporting violations, says Beth Schroeder, chair of Raines Feldman LLP's labor and employment group.
A recent Expert Analysis article titled “Challenges In Billing Physician Observation Services” needlessly raises concern among hospitals and physicians about proper billing by physicians for Medicare observation services, says Sheree Kanner of Hogan Lovells.
While the U.S. Department of Health and Human Services Office of Civil Rights has been quiet recently with respect to Health Insurance Portability and Accountability Act enforcement actions, the newly empowered EU data protection authorities will be eager to flex their muscles and show that the General Data Protection Regulation’s extraterritorial reach is not only real, but that noncompliance can be painful, say Nancy Libin and David Saunders of Jenner & Block LLP.
In a profession notoriously averse to change, it should come as no surprise that there is skepticism about the value of having attorneys perform nonbillable tasks. But U.S. law firms have slowly begun to incorporate knowledge lawyers into their operations — and the trend is likely to continue, says Vanessa Pinto Villa of Hogan Lovells.
The Ninth Circuit’s decision last month in Planned Parenthood v. Center for Medical Progress has effectively turned the anti-SLAPP motion into a hybrid of typical motions to dismiss and motions for summary judgment. As a result, defendants have lost the primary benefit of the anti-SLAPP process, says Joseph Gjonola of Roxborough Pomerance Nye & Adreani LLP.